Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2020-05-01
|
| Series: | European Cardiology Review |
| Online Access: | https://www.ecrjournal.com/articleindex/ecr.2020.15.1.PO9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850256670575296512 |
|---|---|
| author | M Rizzo I Colomer-Asenjo G Cabello-Molina S Marín-López M Sutil-Vega C Roca-Guerrero F Taibi-Hajjami D García-Vega M Panelo-Rubio M Bonastre-Thio A Martínez-Rubio |
| author_facet | M Rizzo I Colomer-Asenjo G Cabello-Molina S Marín-López M Sutil-Vega C Roca-Guerrero F Taibi-Hajjami D García-Vega M Panelo-Rubio M Bonastre-Thio A Martínez-Rubio |
| author_sort | M Rizzo |
| collection | DOAJ |
| format | Article |
| id | doaj-art-13a7748dffbb483bbadb61a818cf6ee8 |
| institution | OA Journals |
| issn | 1758-3756 1758-3764 |
| language | English |
| publishDate | 2020-05-01 |
| publisher | Radcliffe Medical Media |
| record_format | Article |
| series | European Cardiology Review |
| spelling | doaj-art-13a7748dffbb483bbadb61a818cf6ee82025-08-20T01:56:35ZengRadcliffe Medical MediaEuropean Cardiology Review1758-37561758-37642020-05-0115e3210.15420/ecr.2020.15.1.PO9Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection FractionM Rizzo0I Colomer-Asenjo1G Cabello-Molina2S Marín-López3M Sutil-Vega4C Roca-Guerrero5F Taibi-Hajjami6D García-Vega7M Panelo-Rubio8M Bonastre-Thio9A Martínez-Rubio10Sabadell, Barcelona, SpainSabadell, Barcelona, SpainSabadell, Barcelona, SpainSabadell, Barcelona, SpainSabadell, Barcelona, SpainSabadell, Barcelona, SpainSabadell, Barcelona, SpainSabadell, Barcelona, SpainSabadell, Barcelona, SpainSabadell, Barcelona, SpainSabadell, Barcelona, Spainhttps://www.ecrjournal.com/articleindex/ecr.2020.15.1.PO9 |
| spellingShingle | M Rizzo I Colomer-Asenjo G Cabello-Molina S Marín-López M Sutil-Vega C Roca-Guerrero F Taibi-Hajjami D García-Vega M Panelo-Rubio M Bonastre-Thio A Martínez-Rubio Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction European Cardiology Review |
| title | Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction |
| title_full | Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction |
| title_fullStr | Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction |
| title_full_unstemmed | Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction |
| title_short | Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction |
| title_sort | tolerability profile and discontinuation causes of sacubitril valsartan treatment in real life patients with heart failure and reduced ejection fraction |
| url | https://www.ecrjournal.com/articleindex/ecr.2020.15.1.PO9 |
| work_keys_str_mv | AT mrizzo tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction AT icolomerasenjo tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction AT gcabellomolina tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction AT smarinlopez tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction AT msutilvega tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction AT crocaguerrero tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction AT ftaibihajjami tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction AT dgarciavega tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction AT mpanelorubio tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction AT mbonastrethio tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction AT amartinezrubio tolerabilityprofileanddiscontinuationcausesofsacubitrilvalsartantreatmentinreallifepatientswithheartfailureandreducedejectionfraction |